Trial Protocol ID USOR 21270_ZN-c3-005 GOG3066 *STAR*

Trial Description

A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN‑C3 in Subjects with High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ZN-c3-005| GOG 3066)

Contact us regarding Clinical Trials at or call us at 877-664-7724


  • Syed Shahid Mahmood, M.D.

Disease Types


  • K-Group Beta, Inc. NCT ID

  • NCT05128825